Biased Agonism, Partial Agonism and the Importance of Comprehensive Functional Screening in Drug Development
Read Dr Mark Bird's blog about the importance of measuring the G-protein in biased agonism and partial...
Methylone is a rapid-acting neuroplastogen with less off-target activity than MDMA, published in Frontiers in Neuroscience (vol 18, Feb 2024).
Gifford Bioscience contributes its receptor pharmacology expertise to the study of the effect of methylone...
Which Receptor Ligand Binding Technique? Download Our Guide.
Not sure which technique is right your your study of receptor-ligand interaction? Download our interactive...
Celebrating the International Day of Women and Girls in Science, February 11th
Three of our female scientists talk about what inspired them to a career in science. Video Link - Click Here...
ELRIG 2023 – We’re Exhibiting
Gifford Bioscience will be exhibiting at this year's ELRIG – Drug Discovery meeting in Liverpool on the 18th and...
Download Our Latest Price Guide
We have updated our price guide, adding further tables for our standard assays and new tiers for volume discounts....
Our New Principal Investigator, Dr Sarah Routledge
Sarah joined Gifford Bioscience in 2021, following 10 years of post-doctoral research at the Universities of...
An Introduction To Gifford Bioscience
Watch our Corporate Video to find out more about who we are and the assays that we do. An introduction to our...
ELRIG 22 Poster Presentation
Gifford Bioscience will be attending ELRIG Drug Discovery in London on the 4th-5th October 2022. Dr Maria Azam; Dr...
Contact Us
This site is protected by reCAPTCHA. The information you supply will be processed in accordance with the General Data Protection Regulation (EU & UK). For further details, please refer to our Privacy Policy.
Copyright © 2024 Gifford Bioscience Limited
Privacy Policy